Bain, Pfizer launch biotech startup to tackle brain disorders

Bain, Pfizer launch biotech startup to tackle brain disorders


Bain Capital LP and Pfizer Inc. have teamed up to launch a new biotech in the Boston area focused on neurological disorders, including Parkinson's and Alzheimer's disease. The new company, called Cerevel Therapeutics LLC, is starting out with a $350 million investment from funds affiliated with Bain.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога